Intellia Therapeutics, Inc. (NASDAQ:NTLA) Stock Now Rated "Hold" by Wall Street Brokerages
MarketBeat
Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) has received a consensus recommendation of "Hold" from the twenty-one analysts that are presently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine
NASDAQ:NTLA